TACR1 and neoplasm: Tumor cell migration is induced by peptides (e.g., SP) and classical neurotransmitters (dopamine, noradrenaline); this migration is inhibited after D2 receptor, adrenoceptor or NK-1 receptor antagonists [10,60] are administered.